A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naive HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz.
about
Efavirenz-Based Regimens in Antiretroviral-Naive HIV-Infected Patients: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsRole of traditional risk factors and antiretroviral drugs in the incidence of chronic kidney disease, ANRS CO3 Aquitaine cohort, France, 2004-2012Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz.Ritonavir-boosted darunavir is rarely associated with nephrolithiasis compared with ritonavir-boosted atazanavir in HIV-infected patientsCystatin C-based renal function changes after antiretroviral initiation: a substudy of a randomized trial.Protease Inhibitors and Renal Function in Patients with HIV Infection: a Systematic Review.Systematic Literature Review and Meta-Analysis of Renal Function in Human Immunodeficiency Virus (HIV)-Infected Patients Treated with Atazanavir (ATV)-Based Regimens.Reductions in Plasma Cystatin C After Initiation of Antiretroviral Therapy Are Associated With Reductions in Inflammation: ACTG A5224s.Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals.Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study.Cystatin C Falsely Underestimated GFR in a Critically Ill Patient with a New Diagnosis of AIDS.Estimated Glomerular Filtration Rate Trajectories in HIV-Infected Subjects Treated With Different Ritonavir-Boosted Protease Inhibitors and Tenofovir Disoproxil Fumarate or Abacavir.Exploratory Analysis for the Evaluation of Estimated Glomerular Filtration Rate, Cholesterol and Triglycerides after Switching from Tenofovir/Emtricitabine plus Atazanavir/Ritonavir (ATV/r) to Abacavir/Lamivudine plus ATV/r in Patients with PreserveHIV therapies and the kidney: some good, some not so good?Systematic review of renal and bone safety of the antiretroviral regimen efavirenz, emtricitabine, and tenofovir disoproxil fumarate in patients with HIV infection.Estimated glomerular filtration rates through 144 weeks on therapy in HIV-1-infected subjects receiving atazanavir/ritonavir and abacavir/lamivudine or simplified to unboosted atazanavir/abacavir/lamivudine.Incidence of renal toxicity in HIV-infected, antiretroviral-naïve patients starting tenofovir/emtricitabine associated with efavirenz, atazanavir/ritonavir, or lopinavir/ritonavir.High incidence of renal stones among HIV-infected patients on ritonavir-boosted atazanavir than in those receiving other protease inhibitor-containing antiretroviral therapy.Antiretroviral therapy as a risk factor for chronic kidney disease: Results from traditional regression modeling and causal approach in a large observational study.ARIES 144 week results: durable virologic suppression in HIV-infected patients simplified to unboosted atazanavir/abacavir/lamivudine.
P2860
Q28081266-989CC93A-6C1B-4B96-BCCB-EBDF4CB3447DQ28533843-05A8A8F3-6B71-4AC3-9D2F-E689523282A9Q34158739-855F62DE-F74C-4F4D-8DBC-5B0E15CA20DCQ35018821-62B31601-6A85-4150-BAD3-24C6260C385DQ35071954-61BEC767-93B4-4350-A4B5-8F098802E259Q35186842-2EA60B61-3948-4DC9-BDA7-A47FF9F15216Q35566732-A8BCB0C2-E40E-4595-9AAD-CCE273867CFCQ35652795-32BCD52A-CB4C-467D-8E26-6649B17C9FA9Q36687721-08CD1CF8-46F1-4C14-B707-A269B5B6408FQ36723349-60A8FF68-FF91-49E4-A0A8-8EB2EB2B847AQ36949175-EFEDCCA9-3C2F-4DB9-9892-4764DFF43DAEQ36988748-4C256BB0-A947-4F2F-A93A-2EC683D16F29Q37141511-274BE990-4F7E-46F8-B19C-7E656B9F3CACQ37988776-D46B27E1-6F4E-4D04-87DC-06FC9A730A05Q38997526-F770541A-8912-4875-A6E6-C936181F5CC0Q41128689-B9F0EFE2-FC6C-4511-90C3-54618D146033Q43876123-7D507B50-FEA1-4110-A206-3E49C3F733B4Q44878422-75B22318-CEEA-4885-92AC-62C194A165A1Q47094903-A891A1F6-F006-4554-88B3-5A04A9658E39Q51349356-BA005312-1A8C-4551-B866-C30381DE67F4
P2860
A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naive HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A randomized, pilot trial to e ...... anavir/ritonavir or efavirenz.
@en
type
label
A randomized, pilot trial to e ...... anavir/ritonavir or efavirenz.
@en
prefLabel
A randomized, pilot trial to e ...... anavir/ritonavir or efavirenz.
@en
P2093
P1476
A randomized, pilot trial to e ...... anavir/ritonavir or efavirenz.
@en
P2093
Alessandra Calabresi
Bruno Mario Cesana
Carlo Torti
Daria Gotti
Davide Motta
Emanuele Focà
Giuseppe Lapadula
Ilaria Izzo
Laura Albini
Laura Sighinolfi
P356
10.1097/QAI.0B013E31823A6124
P407
P577
2012-01-01T00:00:00Z